However, their tumor-killing ability is counteracted by various factors, such as indoleamine 2,3-dioxygenase (IDO), vascular endothelial growth factor (VEGF), interleukin 10 (IL-10), hypoxia, and CD4+ T-cell deprivation (35). The gene discussed is CD4; the disease is neoplasm.